Protocol Compliance [GxP / QC / QA]

posted by raghavendra_s – 2010-04-03 11:53 (5915 d 10:19 ago) – Posting: # 5006
Views: 8,245

Dear Madam/Sir,

In BA/BE study, if a Subject is lost to followup i.e., he has not given safety analysis and he comes after 2 months of the last dose. But protocol says safety analysis must be taken within 30 days of the last dose. In this regard, what to do?

Thanks in advance.

Kind Regards,

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
111 visitors (0 registered, 111 guests [including 17 identified bots]).
Forum time: 22:12 CEST (Europe/Vienna)

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking.    Stuart J. Pocock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5